Diamedica Therapeutics's total assets for Q2 2025 were $31.47M, a decrease of -18.95% from the previous quarter. DMAC total liabilities were $4.30M for the fiscal quarter, a -11.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.